Preparation of polycaprolactone nanoparticles via supercritical carbon dioxide extraction of emulsions by Ajiboye, Adejumoke Lara et al.
ORIGINAL ARTICLE
Preparation of polycaprolactone nanoparticles via supercritical
carbon dioxide extraction of emulsions
Adejumoke Lara Ajiboye1 & Vivek Trivedi1 & John C. Mitchell1
# The Author(s) 2017. This article is an open access publication
Abstract Polycaprolactone (PCL) nanoparticles were pro-
duced via supercritical fluid extraction of emulsions (SFEE)
using supercritical carbon dioxide (scCO2). The efficiency of
the scCO2 extraction was investigated and compared to that of
solvent extraction at atmospheric pressure. The effects of pro-
cess parameters including polymer concentration (0.6–10%
w/w in acetone), surfactant concentration (0.07 and 0.14%
w/w) and polymer-to-surfactant weight ratio (1:1–16:1 w/w)
on the particle size and surface morphology were also inves-
tigated. Spherical PCL nanoparticles with mean particle sizes
between 190 and 350 nm were obtained depending on the
polymer concentration, which was the most important factor
where increase in the particle size was directly related to total
polymer content in the formulation. Nanoparticles produced
were analysed using dynamic light scattering and scanning
electron microscopy. The results indicated that SFEE can be
applied for the preparation of PCL nanoparticles without ag-
glomeration and in a comparatively short duration of only 1 h.
Keywords Solvent extraction . Polycaprolactone .
Nanoparticles . Supercritical carbon dioxide . Supercritical
fluid extraction of emulsions
Introduction
The use of drug delivery systems, particularly the micro- and
nano-scale intelligent systems for therapeutic molecules has
rapidly increased over the years because they can successfully
maximise the efficacy of the drug molecules [1].
Nanoparticles are particles with a diameter range from 1 to
100 nm, even though the dynamic range can cover the whole
nanometre scale [2]. As a drug delivery system, nanoparticles
can entrap drugs or biomolecules into their internal structures
and/or adsorb these drugs or biomolecules onto their external
surfaces [3].
Due to their particle size, nanoparticles can move freely
through the body via the smallest capillary vessels, cell and
tissue gaps in order to reach their target organs [4]. These
properties of nanoparticles help to modify the bio-
distribution and pharmacokinetic properties of the adsorbed/
entrapped drug molecules leading to an improvement in the
efficacy of the drug, decrease in unwanted side-effects and
increase in patient compliance [5]. Nanoparticles can be pre-
pared from inorganic or polymeric materials. Polymeric nano-
particles are more common and appropriate as they can be
chemically modified to be biodegradable and biocompatible
[6]. Biodegradable substances are broken down in vivo either
enzymatically or non-enzymatically or both, to give rise to
toxicologically safe by-products which are further removed
by the normal metabolic pathways. The use of biodegradable
polymers has greatly increased over the past decade, and they
can generally be classified as either (1) synthetic biodegrad-
able polymers which include relatively hydrophobic materials
for example poly-lactic-co-glycolic acid (PLGA),
polycaprolactone (PCL) and others, or (2) naturally occurring
polymers such as chitosan, hyaluronan, etc. [7]. Principally,
synthetic polymers have many inherent advantages since their
structures can be manipulated to generate specialised carriers
to suit particular applications [8].
PCL is a semi-crystalline polyester that is hydrophobic,
biodegradable and biocompatible. When compared to other
polymers, the biodegradation of PCL is slow; hence, it can
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be highly suitable for the design of controlled release delivery
systems [9–11]. The glass transition temperature (Tg) of
− 60 °C and low melting point (59–64 °C) of PCL allows
for the easy fabrication of delivery systems at reasonably
low temperatures [10]. Furthermore, PCL has an excellent
blend compatibility with other polymers which facilitates tai-
loring of desired properties like degradation kinetics, hydro-
philicity and mucoadhesion [12, 13].
In the last decades, PCL polymers have been a key area of
interest in the development of controlled delivery systems espe-
cially for peptides and proteins [14]. These systems using PCL
or PCL blends have shown to be useful in varied conditions. For
example, while developing PCL microspheres for vaccine de-
livery, Jameela et al. showed that PCL has good permeability to
proteins and contrary to poly (lactic acid) PLA and poly glycolic
acid (PGA), PCL degrades very slowly and does not give rise to
an acidic environment which can negatively affect the antigenic-
ity of the vaccine, and thus, it can be used as a vaccine carrier
[15]. Observations by Youan et al. also suggested that PCL
delivery systems are unaffected by simulated gastric fluid and
hence could give some protection to the encapsulated peptide
from proteolytic destruction in the stomach, allowing the
entrapped drugs to pass unharmed into the intestine for presen-
tation to the gut-associated lymphoid system [16].
Various techniques can be employed to prepare nanoparticles,
many of which involve a type of emulsion evaporation. The
preparation of nano-emulsions via spontaneous emulsification
mechanism using a water-miscible solvent is an established
method that allows for the generation of nano-sized droplets
[17]. Nano-emulsions are made of fine oil-in-water dispersions
with droplet sizes ranging from 100 to 600 nm. They can be
prepared using a small surfactant concentration and they typical-
ly exhibit low oil-water interfacial tensions. Spontaneous emul-
sification occurring when the organic and aqueous phases are in
contact determines the droplet size and size distribution, and
depends on variables including bulk viscosity, surfactant con-
centration and structure [17–19]. In this work, the organic phase
consists of a homogenous solution of the polymer in a water-
miscible solvent (acetone) and surfactant which is mixed with
the aqueous phase to produce nano-emulsion.
Although emulsification of polymer mixtures is known to be
an efficient method, it can be associated with limitations
concerning process efficiency and control of the particle size
and distribution when particles are being recovered from the
emulsion through conventional processes [20]. Supercritical flu-
id extraction of emulsion (SFEE) is a novel particle formation
technique where it employs a supercritical fluid (SCF) such as
supercritical carbon dioxide (scCO2) to rapidly extract the sol-
vent or oil phase of an emulsion. The removal of the solvent
leads to the precipitation of the solute resulting into an aqueous
suspension containing nanoparticles. Particles can thereafter be
recovered from the aqueous suspension by centrifugation and/or
by evaporation at room temperature [21]. Particles generated via
SFEE have an ordered size and morphology because emulsifi-
cation process provides a template and the fast kinetics of the
scCO2 extraction prevents particle agglomeration [22].
The aim of this work was to produce polymeric nanoparticles
by employing scCO2 extraction of the solvent in the organic
phase of nano-emulsions prepared via spontaneous emulsifica-
tion. Themajor objective of this workwas to study the suitability
of SFEE and the effect of various parameters influencing the
preparation of nanoparticles using PCL as a model polymer.
The effect of parameters including polymer and surfactant con-
centration on the particles’ hydrodynamic diameter, polydisper-
sity index (PDI) and zeta potential was investigated. The time
and the optimum CO2 flow rate were also determined for the
complete extraction of oil phase/solvent at both high pressures in
scCO2 and atmospheric conditions.
Experimental section
Materials
PCL (Mw = 45,000 Da) was obtained from Shenzhen ESUN,
China, and Tween 80 and acetone were purchased from Sigma
Aldrich, UK. Liquid CO2 at 99.9% was supplied by BOC Ltd.,
UK. All chemicals were of analytical grade and used without




The nano-emulsions were prepared through spontaneous emul-
sification mechanism. The method used for the preparation of
PCL emulsions was adapted from the work reported by Prieto
and Calvo [22]. The organic phase consists of a homogenous
solution of PCL in acetone and Tween 80, while deionised water
made up the aqueous phase. In summary, an appropriate quantity
of PCL was first dissolved in acetone (0.6–10% w/w) in a ther-
mostatic water bath at 40 °C, before the addition of surfactant in
a centrifuge tube to obtain required concentrations (0.07 and
0.14%) or ratios (1:1–16:1 w/w). The contents in the tube were
mixed together using a vortex mixer for 1 min. After vortexing,
35.8 g of warm deionised water (40 °C) was added, and the tube
was placed back on the vortex mixer for 5 min in order to form a
homogenous emulsion. Solvent extraction was carried out im-
mediately after emulsion was prepared.
Solvent extraction via SFEE
SFEEwas conducted in a batch mode where 25-g emulsion was
introduced in the high-pressure vessel (Thar Process Inc., USA)
pre-heated to 40 °C (± 2 °C), the vessel was then closed and
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liquid CO2 was pumped until a pressure of 100 bar was
achieved. The system was left to equilibrate under stirring for
15 min before continuously flushing with fresh CO2 for 1 h. The
initial experiments were carried out at controlled scCO2 flow
rates of 1, 4 or 10 g/min to determine the extraction efficiency
of scCO2. The system was then depressurised at a rate of 6 bar/
min, and the sample was removed from the high-pressure vessel.
The acetone extraction efficiency was calculated using the
weight difference before and after the procedure.
Solvent extraction at atmospheric pressure
Solvent extraction at atmospheric pressure was conducted at
40 °C (± 2 °C) in a thermostatic water bath (Fisher Scientific,
UK) with 25-g emulsion in a 50-ml beaker, at a stirring rate of
300 rpm. The evaporation of acetone was determined at time 0,
1, 2, 3, 4 and 24 h using weight difference similar to SFEE.
Physicochemical characterisation of nanoparticle
Particle size and zeta potential measurement
These measurements were carried out in order to determine
the size and surface charge of the nanoparticles. The average
particle sizes and polydispersity index (PDI) were measured
by dynamic light scattering (DLS) using a Zetasizer Nano-ZS
(Malvern Instruments Ltd., UK). The instrument was
equipped with a laser emitting at 633 nm, and backscattering
detection was set at an angle of 173°. Samples were diluted in
deionised water (1 in 4) and measurements were carried out in
triplicate at room temperature (25 °C). The mean particle size
was the average of three independent measurements. The zeta
potential (Z-potential) of the aqueous dispersions was also
determined using Zetasizer Nano-ZS at 25 °C. The measure-
ments were carried out in triplicate on the same samples used
for particle size measurements.
Particle morphology
Scanning electron microscopy (SEM) was performed in order to
determine the shape and surface morphology of the nanoparti-
cles. The frozen aqueous nanoparticle dispersions were freeze-
dried under vacuum at − 55 °C using a ScanVac CoolSafe freeze
dryer (LaboGene ApS, Denmark). Approximately 1 mg of the
dried particles was placed on the sample stub using a carbon
adhesive and the extra loose particles were removed. The sample
was then coated with chromium, thereafter the stub was
mounted onto the sample holder and placed inside the Hitachi
SU8030 (Hitachi High-Technologies, UK) scanning electron
microscope. Micrographs were collected using the upper detec-
tor at a voltage of 1.0 kV.
Results and discussion
Solvent extraction
The rate of acetone extraction via supercritical processing was
evaluated. The temperature (40 °C) and pressure (100 bar)
selected for SFEE were based on the low melting point (59–
64 °C) of the PCL polymer and the goodmiscibility of acetone
with scCO2 at these conditions [23]. Figure 1 shows that at a
constant exposure time of 1 h, the percentage weight of ace-
tone extracted from the emulsion increases with an increasing
flow rate of scCO2. Complete removal of acetone occurred
after 1 h at a CO2 flow rate of 10 g/min. Extraction of the
organic phase can occur either by diffusion mechanism in the
aqueous phase or by direct extraction upon contact between
acetone and scCO2 in the emulsion droplet. Thus, acetone
extraction at higher scCO2 flow rates improves as it allows
for a comparatively large quantity of CO2 to be in contact with
the emulsion and consequently the organic phase [24].
The rate of acetone extraction at atmospheric conditions
was also evaluated and compared to scCO2 conditions.
Acetone extraction at atmospheric pressure was carried out
at 40 °C to obtain comparative data at the same temperature
used in supercritical fluid extraction. Also, the conditions used
in these experiments allowed the work to be carried at a tem-
perature below the melting point of PCL (59–64 °C) to avoid
possible particle deformation due to simultaneous melting of
the polymer. The complete removal of acetone at atmospheric
pressure (Fig. 2) could only be obtained after 24 h of contin-
uous stirring at 40 °C.
Moreover, the extraction at atmospheric pressure also led to
the agglomeration of particles (Fig. 2, inset) consequently de-
creasing the total product yield. The gas-like viscosity of scCO2
coupled with high diffusivity facilitates the rapid and efficient
extraction of acetone in comparison to solvent extraction at
atmospheric pressure at the same temperature without particle
agglomeration [25]. Based on these findings (rapid extraction
time and no aggregation at scCO2 conditions), SFEE was cho-
sen as the method for solvent removal for the rest of the study.
The extraction conditions were kept constant with a scCO2
flow rate of 10 g/min for 1 h at 100 bar and 40 °C.
Fig. 1 Acetone extraction via SFEE
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Effect of polymer concentration
PCL content was varied between 0.6 and 10% w/w, and the
effects of polymer concentration on the morphological char-
acteristics and surface charge of the particles were
investigated.
As noted in Fig. 3, at a constant surfactant concentration
(0.07% w/w) and water-to-acetone ratio (2.5:1), an increase in
polymer concentration results in an increase in particle size.
These results are in line with findings of Santos et al. [26] and
Kwon et al. [27]. Primarily, it is assumed that nanoparticle
formation occurs when both the organic and aqueous phases
are in contact. The solvent diffuses from the organic part into
the aqueous and takes along with it some polymer chains
which are still in solution, then as the solvent spreads further
into the water, the accompanying polymer chains aggregate
forming nanoparticles [28]. A rise in the polymer content in
the organic phase consequently increases both its hydrophobic
composition and viscosity which is relative to a higher mass
transfer resistance, hence leading to a negative effect on the
distribution efficiency of the polymer-solvent composition in-
to the external aqueous phase and the formation of large
nanoparticles [27, 28]. The results also show a marked differ-
ence between the size before and after acetone extraction,
which could be due to the presence of voids in the polymer
matrix which collapse upon the extraction of acetone by
scCO2. It is well known that free spaces within the polymer
network caused by the presence of a solvent can cause parti-
cles to shrink and reduce in size after drying [29].
The particle surface charge was determined by carrying out
Z-potential measurements. Table 1 presents the Z-potential
values of PCL nanoparticles prepared with different polymer
concentrations. Nanoparticles produced have a negative sur-
face charge which can be as a result of the carbonyl group of
the PCL polymer present at the surface of the nanoparticle
structure. Table 1 also shows a shift in Z-potential values with
an increasing polymer concentration. The change in Z-poten-
tial can be attributed to the shielding effect by the surfactant
molecules at the interface due to interaction with PCL.
Therefore, as the polymer content increases at a constant sur-
factant concentration, the number of Tween 80 molecules
available at the interface decreases consequently resulting in
a reduced shielding effect and leading to a change in Z-poten-
tial [30]. Table 1 also presents PDI of produced nanoparticles
Table 1 PDI and Z-potential of PCL particles before and after
extraction of a 25-g emulsion (0.6–10%w/w PCL, 28.3%w/w of acetone,
71.6% w/w of distilled water and 0.07% w/w surfactant)
PCL concentration







0.6 0.13 ± 0.07 0.11 ± 0.10 −10 ± 1
1 0.19 ± 0.06 0.09 ± 0.07 −12 ± 1
2 0.09 ± 0.07 0.16 ± 0.08 −15 ± 2
4 0.17 ± 0.04 0.22 ± 0.04 −24 ± 1
6 0.23 ± 0.07 0.27 ± 0.04 −21 ± 0
8 0.21 ± 0.05 0.27 ± 0.02 −24 ± 1















PCL concentraon (%w/w in acetone)
0.07% conc.
0.14% conc.
Fig. 4 Comparison of the mean emulsion droplet size (nm) of 0.07 and
0.14% w/w surfactant concentrations at a constant PCL concentration



















PCL concentraon (% w/w in acetone)
Droplet size
Parcle size
Fig. 3 The effect of PCL concentration in the organic phase on the
average sizes before and after SFEE
Fig. 2 Acetone extraction at atmospheric pressure. Inset: an image of
typical agglomerate seen after acetone extraction at 40 °C
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at various polymer concentrations. In general, the PDI was
very low for all formulations, confirming that the prepared
nanoparticles are highly monodisperse and have narrow par-
ticle size distribution. A slight increase in PDI was observed
with the increase in polymer concentration and particle size.
This could be attributed to the increase in viscosity of the
organic phase and possible coalescence of smaller droplets
into larger droplets at higher concentrations resulting in com-
paratively broad particle size distribution [31, 32].
Effect of surfactant concentration
In order to investigate the effect of surfactant on the particle
size, PDI and surface charge, at a constant polymer concen-
tration, the surfactant content was doubled from 0.07 to 0.14%
w/w.
As observed in Fig. 4, there is a general increase in droplet
size as polymer concentration increases. Furthermore, an in-
crease in surfactant concentration resulted in smaller droplet
size which was more evident at higher polymer concentra-
tions. This result is similar to the findings from the work done
by Goloub and Pugh [33]. The positive effect of a higher
Tween 80 concentration on droplet size can be easily related
to the role of Tween 80 in the emulsion. A low concentration
of surfactant in the emulsion and consequently at the solvent-
water interfacial layer would mean that there is not enough
surfactant to cover the surface of drops, resulting in coales-
cence of droplets and increase in size. An increase in the
surfactant concentration would therefore result in a higher
number of surfactant molecules present at the interfacial layer
promoting the formation of smaller droplets [34].
Similar to earlier observations, an increase in polymer con-
centration at a constant surfactant concentration generally re-
sulted in an increase in particle size. As noted when Figs. 4
and 5 are compared, there is also a reduction in size after
acetone extraction by SFEE.
Figure 5 also shows that a higher surfactant concentration
led to decrease in particle size and standard error. This result is
similar to that reported byMu and Feng [35]. The reduction in
size can also be anticipated from the role of surfactant as an
emulsion stabiliser in the formation of nanoparticles [36].
Z-potential measurements (Table 2) were determined on
0.14% w/w Tween 80 samples to understand the effect of the
surfactant concentration on the particle surface charge. Similar
to earlier results, Z-potential increased with the polymer con-
centration but no significant change could be observed with
the higher surfactant content in these samples.
Table 2 PDI and Z-potential of PCL nanoparticles before and after
SFEE of a 25-g emulsion (0.6–10% w/w, 28.3% w/w of acetone, 71.6%
w/w of distilled water and 0.14% w/w surfactant)
PCL concentration






± SD after SFEE
0.6 0.09 ± 0.03 0.11 ± 0.05 −14 ± 1
1 0.14 ± 0.05 0.19 ± 0.04 −17 ± 3
2 0.09 ± 0.04 0.14 ± 0.07 −19 ± 3
4 0.14 ± 0.08 0.19 ± 0.08 −22 ± 2
6 0.16 ± 0.06 0.22 ± 0.12 −25 ± 3
8 0.19 ± 0.04 0.26 ± 0.09 −29 ± 3






























Fig. 6 Mean emulsion droplet size at a varying polymer-to-Tween 80
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Fig. 7 Mean particle size after SFEE at a varying polymer-to-Tween 80























PCL concentraon (% w/w in acetone)
0.07% conc.
0.14% conc.
Fig. 5 Contrast of the mean particle size (nm) of 0.07 and 0.14% w/w
surfactant concentrations after SFEE at a constant PCL concentration (%
w/w in acetone)
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Like the previous results, the PDI recorded for the higher
surfactant concentration samples (Table 2) are very low for all
the preparations and they indicate that the nanoparticles pro-
duced have a uniform particle size distribution.
Effect of polymer-to-surfactant weight ratio
To further study the effect of varying surfactant/polymer con-
tent on nanoparticle formation, the concentrations were altered
to prepare emulsions with polymer-to-surfactant weight ratios
of 1:1, 2:1, 4:1, 8:1 and 16:1.
As shown in Figs. 6 and 7, similar to previously discussed
findings, at a constant polymer-to-surfactant weight ratio, in-
creasing polymer concentration led to the formation of larger
particles. Interestingly, 1:1 w/w ratio samples have noticeably
higher particle size in comparison to the rest of the data sets.
This could be attributed to the depletion effect from non-
adsorbing Tween 80 micelles at such high surfactant concen-
tration [37]. The presence of free micelles at high surfactant
concentrations can cause increase in osmotic pressure in the
liquid surrounding the particles to an extent which can result
in particle aggregation [38].
It is also important to note that the error associated to the
particles prepared with 1:1 w/w ratio is also very high in com-
parison to other formulations which suggest flocculation/
aggregation of prepared particles. There were minimal changes
in particle sizes at polymer-to-surfactant weight ratio from 16:1
to 2:1 w/w. These results suggest that it may be possible to pre-
pare PCL nanoparticles in wide ranging sizes using extremely
high surfactant-to-polymer ratio but factors mentioned above are
important to be considered. However, particle sizes ranging from
150 to 350 nm with narrow distribution can be reproducibly
obtained using low to moderately high surfactant concentrations.
Particle morphology
SEM micrographs were obtained using chromium-coated
freeze-dried PCL nanoparticles in order to investigate the
shape and surface morphology of produced particles.
Figure 8 presents an example of micrographs of PCL nano-
particles prepared by SFEE.
From the SEM micrographs, it is clearly seen that the par-
ticles prepared by SFEE are spherical and generally with uni-
form particle size distribution. SEMmicrographs also confirm
DLS results that there is an increase in particle size at a higher
polymer concentration.
Conclusion
Spherically shaped monodisperse polycaprolactone nanoparti-
cles have been successfully prepared by supercritical fluid extrac-
tion of emulsions without agglomeration and in a comparatively
short duration. Varying the polymer concentration between 0.6
and 10% w/w during the formulation stage allowed for a control
of the particle size of the resulting polycaprolactone nanoparti-
cles. An increase in the emulsion surfactant concentration from
0.07 to 0.14% w/w at a constant polymer concentration led to a
decrease in particle size. There was minimal change in size when
the polymer-to-surfactant weight ratio was varied between 2:1
and 16:1 w/w ratios. 1:1 w/w polymer-surfactant weight ratio
produced polycaprolactone nanoparticles with sizes between
200 and 500 nm with high standard error between repeats.
Although preliminary studies have shown that these
polycaprolactone nanoparticles can be efficiently produced
via supercritical fluid extraction of emulsions, further studies
investigating their potential to be used as delivery vehicles
either by surface adsorption of a drug or encapsulation within
to provide modified release need to be carried out.
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